Prophylactic Photodynamic Therapy to Organ Transplant Patients
Not Applicable
- Conditions
- Organ Transplants
- Registration Number
- NCT00365521
- Lead Sponsor
- Bispebjerg Hospital
- Brief Summary
To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Organ transplant recipients.
- Age 40 years or older.
Exclusion Criteria
- Patients younger than 40 years and older than 70 years.
- Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion.
- Previous photodynamic therapy to the skin areas investigated.
- Pregnancy or breast feeding patients.
- Patients with porphyria.
- Patients with a tendency to produce hypertrophic scars or keloids.
- Patients with known allergy to Metvix.
- Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bispebjerg Hospital
🇩🇰Copenhagen, Copenhagen NV, Denmark